Sign in

    Devin Sangoi

    Research Analyst at TEJ Investments

    Devin Sangoi is an Analyst at TEJ Investments, specializing in equity research with a focus on technology and healthcare companies such as Alphabet, Microsoft, and Merck. Recognized for his thorough analysis and insightful stock recommendations, he has achieved an estimated success rate of over 68% and generated outsized returns compared to market averages according to third-party performance platforms. Sangoi began his finance career in 2019, previously holding research roles at boutique investment firms before joining TEJ Investments in 2022. He maintains professional credentials including FINRA Series 7 and 63 registrations, and is noted for his rigorous fundamental approach and consistent track record of accurate investment calls.

    Devin Sangoi's questions to Frontline (FRO) leadership

    Devin Sangoi's questions to Frontline (FRO) leadership • Q2 2024

    Question

    Devin Sangoi from TEJ Investments asked about the insurance situation for the 'dark fleet,' the risk of lower oil demand from a potential US recession and slow Chinese recovery, and future capital allocation plans given the potential for high cash flow. He also inquired about the current view on asset acquisition opportunities.

    Answer

    Executive Lars Barstad explained that the lack of recognizable insurance is a defining risk of the 'dark fleet.' He stated that while a global slowdown would limit demand growth, the shrinking compliant fleet provides a buffer. The company's capital allocation policy remains focused on dividends, as current market rates do not justify asset acquisitions or newbuild orders.

    Ask Fintool Equity Research AI